Glioblastoma trials in Singapore

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  Where

  Singapore

  Age

  18 years and over

  People

  450 worldwide

  Run by

  Bayer

  See details and how to joinNCT06914128 · EU 2025-520623-24-00
• Phase 1/2Taking people
  A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  Where

  Singapore

  Age

  Up to 25 years

  People

  75 worldwide

  Run by

  Turning Point Therapeutics, Inc.

  See details and how to joinNCT04094610 · EU 2023-506464-14-00
• Phase 2Taking people
  Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature

  Where

  Singapore

  Age

  21 years and over

  People

  12

  Run by

  National Neuroscience Institute

  See details and how to joinNCT06894225
• Phase 2Taking people
  APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  Where

  Singapore

  Age

  18 years and over

  People

  497 worldwide

  Run by

  Apollomics Inc.

  See details and how to joinNCT03175224 · EU 2024-514542-37-00